Figure 3
From: Mutational spectrum and prognosis in NRAS-mutated acute myeloid leukemia
Kaplan–Meier estimate of overall survival (OS) and event-free survival (EFS) in 152 NRASmut AML. OS and EFS were compared in (a) patients older than 60 years and patients younger than 60 years (b) different risk groups (c) patients who accepted allo-HSCT or not (d) patients with U2AF1 mutations or not.
